{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:54:37Z","timestamp":1789178077754,"version":"build-2803163510"},"reference-count":34,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2018,10,23]]},"DOI":"10.3233\/jnd-180336","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T12:05:54Z","timestamp":1535717154000},"page":"471-480","source":"Crossref","is-referenced-by-count":5,"title":["Low Prevalence Estimates of Late-Onset Glycogen Storage Disease Type II in French-Speaking Belgium are not Due to Missed Diagnoses"],"prefix":"10.1177","volume":"5","author":[{"given":"Gauthier","family":"Remiche","sequence":"first","affiliation":[{"name":"Department of Neurology, Centre de R\u00e9f\u00e9rence Neuromusculaire, H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoltan","family":"Lukacs","sequence":"additional","affiliation":[{"name":"Newborn Screening and Metabolic Diagnostics, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Kasper","sequence":"additional","affiliation":[{"name":"ARCHIMED Life Science GmbH, Vienna, Austria. ARCHIMEDlife Laboratories, Leberstra\u00dfe 20\/2 1110 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Abramowicz","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Pandolfo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Centre de R\u00e9f\u00e9rence Neuromusculaire, H\u00f4pital Erasme, Universit\u00e9 Libre de Bruxelles, Route de Lennik 808, 1070 Brussels, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"1","key":"10.3233\/JND-180336_ref1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.3233\/JND-180336_ref2","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: Implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur J Hum Genet"},{"issue":"9646","key":"10.3233\/JND-180336_ref3","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0140-6736(08)61555-X","article-title":"Reuser AJ. Pompe\u2019s disease","volume":"372","author":"van der Ploeg","year":"2008","journal-title":"Lancet"},{"issue":"3","key":"10.3233\/JND-180336_ref4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/mus.22329","article-title":"Consensus treatment recommendations for late-onset Pompe disease","volume":"45","author":"Cupler","year":"2012","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.3233\/JND-180336_ref5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mus.24149","article-title":"Blood-based diagnostic testing for Pompe disease: Consistency between GAA enzyme activity in dried blood spots and GAA gene sequencing results","volume":"49","author":"Goldstein","year":"2014","journal-title":"Muscle Nerve"},{"issue":"1-2","key":"10.3233\/JND-180336_ref6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2014.07.014","article-title":"Methods of diagnosis of patients with Pompe disease: Data from the Pompe Registry","volume":"113","author":"Kishnani","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.3233\/JND-180336_ref7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1212\/WNL.0000000000002758","article-title":"Prevalence of Pompe disease in 3,076 patients with hyperCKemia and limb-girdle muscular weakness","volume":"87","author":"Lukacs","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JND-180336_ref8","doi-asserted-by":"crossref","unstructured":"Lindberg C , Anderson B , Engvall M , Hult M , Oldfors A. . Search for Pompe disease among patients with undetermined myopathies. Acta Neurol Scand. 2015.","DOI":"10.1111\/ane.12460"},{"issue":"4","key":"10.3233\/JND-180336_ref9","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.ymgme.2015.02.004","article-title":"Delayed diagnosis of late-onset Pompe disease in patients with myopathies of unknown origin and\/or hyperCKemia","volume":"114","author":"Perez-Lopez","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"7","key":"10.3233\/JND-180336_ref10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.nmd.2015.04.008","article-title":"Targeted screening for the detection of Pompe disease in patients with unclassified limb-girdle muscular dystrophy or asymptomatic hyperCK-emia using dried blood: A Spanish cohort","volume":"25","author":"Gutierrez-Rivas","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.3233\/JND-180336_ref11","first-page":"5","article-title":"LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population","volume":"87","author":"Musumeci","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"10.3233\/JND-180336_ref12","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.nmd.2014.06.438","article-title":"Screening for late-onset Pompe disease in Finland","volume":"24","author":"Palmio","year":"2014","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-180336_ref13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ymgme.2013.08.005","article-title":"Late-onset Pompe disease is prevalent in unclassified limb-girdle muscular dystrophies","volume":"110","author":"Preisler","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"2","key":"10.3233\/JND-180336_ref14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2013.03.002","article-title":"Screening for later-onset Pompe\u2019s disease in patients with paucisymptomatic hyperCKemia","volume":"109","author":"Spada","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.3233\/JND-180336_ref15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/mus.21376","article-title":"Screening for Pompe disease using a rapid dried blood spot method: Experience of a clinical diagnostic laboratory","volume":"40","author":"Goldstein","year":"2009","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.3233\/JND-180336_ref16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.nmd.2017.03.005","article-title":"Targeted population screening of late onset Pompe disease in unspecified myopathy patients for Korean population","volume":"27","author":"Lee","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.3233\/JND-180336_ref17","doi-asserted-by":"crossref","unstructured":"Almeida V , Conceicao I , Fineza I , Coelho T , Silveira F , Santos M , et al., Screening for Pompe disease in a Portuguese high risk population. Neuromuscul Disord. 2017.","DOI":"10.1016\/j.nmd.2017.03.010"},{"issue":"11","key":"10.3233\/JND-180336_ref18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.nmd.2016.09.001","article-title":"The frequency of late-onset Pompe disease in pediatric patients with limb-girdle muscle weakness and nonspecific hyperCKemia: A multicenter study","volume":"26","author":"Unver","year":"2016","journal-title":"Neuromuscul Disord"},{"issue":"7","key":"10.3233\/JND-180336_ref19","doi-asserted-by":"crossref","first-page":"4886","DOI":"10.19082\/4886","article-title":"Evaluation prevalence of Pompe disease in Iranian patients with myopathies of unknown etiology","volume":"9","author":"Tehrani","year":"2017","journal-title":"Electron Physician"},{"issue":"1","key":"10.3233\/JND-180336_ref20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ane.12811","article-title":"Screening for late-onset Pompe disease in western Denmark","volume":"137","author":"Hansen","year":"2018","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"10.3233\/JND-180336_ref21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nmd.2017.12.001","article-title":"Prevalence of adult Pompe disease in patients with proximal myopathic syndrome and undiagnosed muscle biopsy","volume":"28","author":"Golsari","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.3233\/JND-180336_ref22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.nmd.2017.12.008","article-title":"A database for screening and registering late onset Pompe disease in Turkey","volume":"28","author":"Gokyigit","year":"2018","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.3233\/JND-180336_ref23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1172\/JCI115025","article-title":"Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice","volume":"87","author":"van der Ploeg","year":"1991","journal-title":"J Clin Invest"},{"issue":"3","key":"10.3233\/JND-180336_ref24","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ymgme.2012.09.015","article-title":"Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa","volume":"107","author":"van der Ploeg","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"4","key":"10.3233\/JND-180336_ref25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"10","key":"10.3233\/JND-180336_ref26","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1136\/jmg.32.10.836-a","article-title":"Glycogen storage disease type II: Frequency of three common mutant alle-les and their associated clinical phenotypes studied in 121 patients","volume":"32","author":"Kroos","year":"1995","journal-title":"J Med Genet"},{"issue":"1","key":"10.3233\/JND-180336_ref27","first-page":"85","article-title":"Frequency of mutations for glycogen storage disease type II in different populations: The delta525T and deltaexon 18 mutations are not generally \"common\" in white populations","volume":"36","author":"Hirschhorn","year":"1999","journal-title":"J Med Genet"},{"key":"10.3233\/JND-180336_ref28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2147\/NDT.S94892","article-title":"Late-onset Pompe disease with complicated intracranial aneurysm: A Chinese case report","volume":"12","author":"Zhang","year":"2016","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.3233\/JND-180336_ref29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12881-014-0141-2","article-title":"Clinical and GAA gene mutation analysis in mainland Chinese patients with late-onset Pompe disease: Identifying c.2238G>C as the most common mutation","volume":"15","author":"Liu","year":"2014","journal-title":"BMC medical genetics"},{"key":"10.3233\/JND-180336_ref30","first-page":"926510","article-title":"Late-Onset Glycogen Storage Disease Type II (Pompe\u2019s Disease) with a Novel Mutation: A Malaysian Experience","volume":"2014","author":"Fu Liong","year":"2014","journal-title":"Case Rep Neurol Med"},{"issue":"6","key":"10.3233\/JND-180336_ref31","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jpeds.2010.11.053","article-title":"Later-onset Pompe disease: Early detection and early treatment initiation enabled by newborn screening","volume":"158","author":"Chien","year":"2011","journal-title":"J Pediatr"},{"issue":"6","key":"10.3233\/JND-180336_ref32","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1007\/s00415-008-0714-0","article-title":"Identification of eight novel mutations of the acid alpha-glucosidase gene causing the infantile or juvenile form of glycogen storage disease type II","volume":"255","author":"Wan","year":"2008","journal-title":"J Neurol"},{"issue":"3","key":"10.3233\/JND-180336_ref33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1006\/bbrc.1998.8255","article-title":"Glycogen storage disease type II: Identification of four novel missense mutations (D645N, G648S, R672W, R672Q) and two insertions\/deletions in the acid alpha-glucosidase locus of patients of differing pheno-type","volume":"244","author":"Huie","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"10.3233\/JND-180336_ref34","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/hmg\/3.7.1081","article-title":"A de novo 13 nt deletion, a newly identified C647W missense mutation and a deletion of exon 18 in infantile onset glycogen storage disease type II (GSDII)","volume":"3","author":"Huie","year":"1994","journal-title":"Hum Mol Genet"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-180336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:34Z","timestamp":1777506814000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-180336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":34,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jnd-180336","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]}}}